Whole genome profiling of small intestine neuroendocrine tumors revealed recurrent mutations in the cyclin dependent kinase inhibitor CDKN1B in only 8% of cases [25]. The gene discussed is CDKN1B; the disease is neuroendocrine neoplasm.